Androgenetic Alopecia in COVID-19: Compared to What?
July 2020
in “
Journal of The American Academy of Dermatology
”
Studysummary This analysis suggests that the reported association between androgenetic alopecia and severe COVID-19 may be overstated, as prevalence rates in patients match expected levels based on prior studies.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study by Wambier et al. proposes an association between androgenetic alopecia (AGA) and severe manifestations of COVID-19. However, the literature cited by Wambier et al. suggests that the prevalence of AGA in hospitalized COVID-19 patients is close to the expected rate. While male sex and older age may be risk factors for COVID-19 mortality, the hypothesis that AGA may be independently associated with severe manifestations of COVID-19 remains a matter of conjecture.
